bioAffinity Technologies effects 1-for-15 reverse stock split effective Aug. 24, 2026

PUBT · 1d ago
bioAffinity Technologies effects 1-for-15 reverse stock split effective Aug. 24, 2026
  • bioAffinity Technologies to execute a 1-for-15 reverse stock split, effective at the open on Aug. 24, 2026.
  • Shares to trade on a post-split basis on Nasdaq under BIAF; move targets compliance with Nasdaq’s minimum bid-price rule.
  • Post-split common stock CUSIP to change to 09076W406; fractional shares to be cashed out.
  • Company expects about 592,373 shares outstanding immediately following the consolidation.
  • Options, incentive plan shares, and warrants to be adjusted proportionately; publicly traded warrant CUSIP to remain unchanged.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. bioAffinity Technologies Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20260820312539) on August 20, 2026, and is solely responsible for the information contained therein.